febuxostat has been researched along with cholecalciferol in 1 studies
Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (cholecalciferol) | Trials (cholecalciferol) | Recent Studies (post-2010) (cholecalciferol) |
---|---|---|---|---|---|
818 | 133 | 710 | 8,234 | 1,425 | 3,471 |
Protein | Taxonomy | febuxostat (IC50) | cholecalciferol (IC50) |
---|---|---|---|
Vitamin D3 receptor | Homo sapiens (human) | 0.087 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amer, AE; El-Kashef, HA; El-Sheakh, AR; Hamed, MF; Nader, MA; Shehatou, GSG | 1 |
1 other study(ies) available for febuxostat and cholecalciferol
Article | Year |
---|---|
Febuxostat attenuates vascular calcification induced by vitamin D3 plus nicotine in rats.
Topics: Animals; Cholecalciferol; Febuxostat; Humans; Nicotine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Vascular Calcification | 2021 |